"AbbVie" percutaneous endoscopic gastrostomy-jejunal tube group
Taiwan·Risk Class 2·AbbVie Deutschland GmbH & CO. KG; CLINICO MEDICAL SP. Z.O.O. BLONIE K/WROCLAWIA·Registered Jun 28, 2017 – Jun 28, 2022Cancelled- Analysis ID
- 69b0ad79bc960f04f559a8a36dde0dcb
- Customs Code
- DHA05602992102
- Manufacturer Country
- Germany;;Poland
- Authorized Representative
- ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND)
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology and urology
- Product Type (Level 2)
- H.5980 Gastric insulal tube and its accessories
- Import Information
- Contract manufacturing;; input
- Registration Date
- Jun 28, 2017
- Expiry Date
- Jun 28, 2022
- Cancellation Date
- Jul 01, 2022
- Status
- Logged out
- Reason
- 自請註銷
Access comprehensive regulatory information for "AbbVie" percutaneous endoscopic gastrostomy-jejunal tube group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 69b0ad79bc960f04f559a8a36dde0dcb and manufactured by AbbVie Deutschland GmbH & CO. KG; CLINICO MEDICAL SP. Z.O.O. BLONIE K/WROCLAWIA. The authorized representative in Taiwan is ABBVIE BIOPHARMACEUTICALS GMBH TAIWAN BRANCH (SWITZERLAND).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.